logo

For the Inventor, By the Inventor

Taipei, Taiwan

Yi-Wen Mao

This inventor holds 8 USPTO granted patents and 3 published patent applications. Top assignees: Syneurx International (Taiwan) Corp., Synenrx International (Taiwan) Corp.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi-Wen Mao. Retrieved from https://idiyas.com/inventor/yi-wen-mao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 

% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal7 out of 31 
 
Syneurx International (Taiwan) Corp.
 patents
silverMedal1 out of 1 
 
Synenrx International (Taiwan) Corp.
 patent

Years Active: 2018-2026

Loading Chart...
8 patents (USPTO):Explore Patents
1. 12521410 - Compounds and pharmaceutical uses thereof (2026-01-13),
2. 11793823 - Compounds and pharmaceutical uses thereof (2023-10-24),
3. 11779561 - Compounds and pharmaceutical uses thereof (2023-10-10),
4. 11382924 - Compounds and pharmaceutical uses thereof (2022-07-12),
5. 11202791 - Compositions containing tannic acids and uses thereof (2021-12-21),
6. 11154531 - Compounds and pharmaceutical uses thereof (2021-10-26),
7. 10265336 - Compositions containing tannic acids and uses thereof (2019-04-23),
8. 10105378 - Enrichment methods for preparing tannic acid compositions (2018-10-23),

Title: The Innovative Mind of Yi-Wen Mao

Introduction

Yi-Wen Mao is a prominent inventor based in New Taipei, Taiwan. With a remarkable portfolio of seven patents, Mao has made significant contributions to the field of pharmaceutical compounds and their therapeutic applications.

Latest Patents

Among his latest innovations are two noteworthy patents focusing on compounds and their pharmaceutical uses. The first patent encompasses a compound represented by Formula (I), which includes a 3 to 7 membered monocyclic ring. This compound includes various substituents, such as halogen and alkyl groups, which open avenues for its therapeutic applications. The second patent presents a method for treating coronavirus infection through the administration of an effective amount of a composition comprising the aforementioned compounds.

Career Highlights

Yi-Wen Mao has made substantial strides in the pharmaceutical industry, notably working with Syneurx International (Taiwan) Corp. His research is at the forefront of developing novel therapeutic strategies, particularly in combating infectious diseases.

Collaborations

Throughout his career, Yi-Wen has collaborated with talented professionals, including Guochuan Emil Tsai and Lu-Ping Lu. Their collective expertise fosters advancements in research and innovation, enhancing the potential of Mao's discoveries and contributions.

Conclusion

With his impressive patent portfolio, Yi-Wen Mao continues to influence the pharmaceutical landscape. His innovative compounds and methodologies hold promise for significant advancements in medical treatments, showcasing the importance of creativity and research in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…